Wen-Hann Tan, MD

Dr. Wen-Hann Tan is a clinical geneticist at Boston Children’s Hospital who has been conducting clinical investigations into Angelman syndrome since 2006.  He currently leads the Angelman Syndrome Natural History Study in North America with 7 study sites in the USA and 3 in Canada.  He has also been a site principal investigator (PI) on many of the therapeutic trials in Angelman syndrome, including the ongoing ASO trial sponsored by Ionis Pharmaceuticals and Biogen.  In addition, he has served on the Angelman Syndrome Foundation Scientific Advisory Committee for the last 12 years.